Sarvajna Dwivedi

Sarvajna Dwivedi, Ph.D. is the Co-Founder, Investor, and Board Member at AngioSafe, Inc., where Sarvajna is focused on solving challenges in complex vascular interventions. Sarvajna has a background in pharmaceutical sciences and has held various leadership roles in companies such as AstraZeneca, Pearl Therapeutics, and Nektar Therapeutics. Sarvajna is known for their expertise in developing early medicines, devices, and new modalities in the pharmaceutical industry.